Literature DB >> 17641010

TNF-alpha drives human CD14+ monocytes to differentiate into CD70+ dendritic cells evoking Th1 and Th17 responses.

Sanju Iwamoto1, Shin-ichi Iwai, Kazuko Tsujiyama, Chika Kurahashi, Kumiko Takeshita, Michio Naoe, Atsuko Masunaga, Yoshio Ogawa, Katsuji Oguchi, Akira Miyazaki.   

Abstract

Many mechanisms involving TNF-alpha, Th1 responses, and Th17 responses are implicated in chronic inflammatory autoimmune disease. Recently, the clinical impact of anti-TNF therapy on disease progression has resulted in re-evaluation of the central role of this cytokine and engendered novel concept of TNF-dependent immunity. However, the overall relationship of TNF-alpha to pathogenesis is unclear. Here, we demonstrate a TNF-dependent differentiation pathway of dendritic cells (DC) evoking Th1 and Th17 responses. CD14(+) monocytes cultured in the presence of TNF-alpha and GM-CSF converted to CD14(+) CD1a(low) adherent cells with little capacity to stimulate T cells. On stimulation by LPS, however, they produced high levels of TNF-alpha, matrix metalloproteinase (MMP)-9, and IL-23 and differentiated either into mature DC or activated macrophages (M phi). The mature DC (CD83(+) CD70(+) HLA-DR (high) CD14(low)) expressed high levels of mRNA for IL-6, IL-15, and IL-23, induced naive CD4 T cells to produce IFN-gamma and TNF-alpha, and stimulated resting CD4 T cells to secret IL-17. Intriguingly, TNF-alpha added to the monocyte culture medium determined the magnitude of LPS-induced maturation and the functions of the derived DC. In contrast, the M phi (CD14(high)CD70(+)CD83(-)HLA-DR(-)) produced large amounts of MMP-9 and TNF-alpha without exogenous TNF stimulation. These results suggest that the TNF priming of monocytes controls Th1 and Th17 responses induced by mature DC, but not inflammation induced by activated M phi. Therefore, additional stimulation of monocytes with TNF-alpha may facilitate TNF-dependent adaptive immunity together with GM-CSF-stimulated M phi-mediated innate immunity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17641010     DOI: 10.4049/jimmunol.179.3.1449

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Quantitative proteomics reveals a role for epigenetic reprogramming during human monocyte differentiation.

Authors:  Dequina Nicholas; Hui Tang; Qiongyi Zhang; Jai Rudra; Feng Xu; William Langridge; Kangling Zhang
Journal:  Mol Cell Proteomics       Date:  2014-10-14       Impact factor: 5.911

2.  Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines.

Authors:  Dong-Hong Lu; Xiao-Yun Guo; Shan-Yu Qin; Wei Luo; Xiao-Li Huang; Mei Chen; Jia-Xu Wang; Shi-Jia Ma; Xian-Wen Yang; Hai-Xing Jiang
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

3.  Optimal stimulation for CD70 induction on human monocyte-derived dendritic cells and the importance of CD70 in naive CD4(+) T-cell differentiation.

Authors:  Kazue Arimoto-Miyamoto; Norimitsu Kadowaki; Toshio Kitawaki; Satoshi Iwata; Chikao Morimoto; Takashi Uchiyama
Journal:  Immunology       Date:  2010-02-26       Impact factor: 7.397

4.  γδ T cells are indispensable for interleukin-23-mediated protection against Concanavalin A-induced hepatitis in hepatitis B virus transgenic mice.

Authors:  Ziyu Meng; Jingya Wang; Yifang Yuan; Guangchao Cao; Shuobing Fan; Chao Gao; Li Wang; Zheng Li; Xiaoli Wu; Zhenzhou Wu; Liqing Zhao; Zhinan Yin
Journal:  Immunology       Date:  2017-02-20       Impact factor: 7.397

5.  Increased CD14+ and decreased CD14- populations of monocytes 48 h after zolendronic acid infusion in breast cancer patients.

Authors:  A Kyrgidis; M P Yavropoulou; R Lagoudaki; C Andreadis; K Antoniades; D Kouvelas
Journal:  Osteoporos Int       Date:  2016-11-17       Impact factor: 4.507

6.  A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes.

Authors:  Dongmei Sun; Xiaoying Zhuang; Xiaoyu Xiang; Yuelong Liu; Shuangyin Zhang; Cunren Liu; Stephen Barnes; William Grizzle; Donald Miller; Huang-Ge Zhang
Journal:  Mol Ther       Date:  2010-06-22       Impact factor: 11.454

7.  IL-36γ/IL-1F9, an innate T-bet target in myeloid cells.

Authors:  Malte Bachmann; Patrick Scheiermann; Lorena Härdle; Josef Pfeilschifter; Heiko Mühl
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

8.  Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma.

Authors:  Kavita M Dhodapkar; Scott Barbuto; Phillip Matthews; Anjli Kukreja; Amitabha Mazumder; David Vesole; Sundar Jagannath; Madhav V Dhodapkar
Journal:  Blood       Date:  2008-07-30       Impact factor: 22.113

9.  Squamous carcinoma cells influence monocyte phenotype and suppress lipopolysaccharide-induced TNF-alpha in monocytes.

Authors:  Aroonwan Lam-ubol; Dustin Hopkin; Elena M Letuchy; Zoya B Kurago
Journal:  Inflammation       Date:  2010-08       Impact factor: 4.092

10.  Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice.

Authors:  Charlotte Andreasen; Daniel A Powell; Nicholas H Carbonetti
Journal:  PLoS One       Date:  2009-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.